Latest: Rama Phosphates Q1 FY27 results →All Q2 FY26 results →
RP

Rama Phosphates

Q2 FY26

Rama Phosphates Q2 FY26: Capex ₹30.41 Cr

Q2 FY26 investor presentation: what the company reported on revenue, margins and capex.

Price₹109
Market cap₹385 Cr
P/E7.2
Updated16 Oct 2026
Read4 min read

Rama Phosphates Q2 FY26 key numbers

Revenue
Year-on-Year (Y-o-Y) increase in revenue: 17% (up by ₹3,620 Lacs from ₹20,946 Lacs in Q2 FY25).

As stated in Rama Phosphates's Q2 FY26 investor presentation · published 16 Oct 2026. Reported figures, not investment advice.

Based on Rama Phosphates's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Revenue from Operations for Q2 FY26: ₹24,566 Lacs - Year-on-Year (Y-o-Y) increase in revenue: 17% (up by ₹3,620 Lacs from ₹20,946 Lacs in Q2 FY25) - Half Year (H1) Revenue FY26: ₹43,597 Lacs, up 20% from ₹36,315 Lacs in H1 FY25 - EBITDA for Q2 FY26: ₹2,711 lakh, up 149% year-on-year - PAT for Q2 FY26: ₹1,728 lakh, up 460% year-on-year - Year-on-year Revenue increase: 17% for the quarter - Margin Outlook: The presentation states strong fundamentals and robust growth, with an emphasis on leveraging technology and proactive R&D to create growth opportunities.

From Rama Phosphates's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Revenue from Operations for Q2 FY26: ₹24,566 Lacs
  • Year-on-Year (Y-o-Y) increase in revenue: 17% (up by ₹3,620 Lacs from ₹20,946 Lacs in Q2 FY25)
  • Half Year (H1) Revenue FY26: ₹43,597 Lacs, up 20% from ₹36,315 Lacs in H1 FY25
  • These indicate an outlook for volume growth.

2 more points from Rama Phosphates's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Rama Phosphates said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Dhule Project:
  • Phase 1: SSP Plant capacity 216,000 MT
  • CAPEX till Q2 FY26: ₹30.41 Cr (₹0.97 Cr funded through term loan)
  • Plant & machinery procured
  • Trial production expected by Q4 FY26
  • Phase 2: Sulphuric Acid Plant capacity 90,000 MT
  • Project cost estimated ₹30 Cr
  • Construction to start last week April 2026
  • Completion by March 2027
  • Capacity Expansion:
  • Strategic debottlenecking of existing plants underway to unlock additional capacity
  • Focus on value-added complex urea fertilizer products and soya division

2 more points from Rama Phosphates's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Rama Phosphates said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Relevant points related to contracts and supplies include: - FY26 SSP contract renewal with Hindustan Urvarak & Rasayan Limited (HURL) for approximately 1 lakh MT reinforces revenue stability and enhances top-line outlook (Page 12). - Import of MOP contributed to strong top-line and bottom-line performance (Page 12).

Rama Phosphates — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹219 Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q2 FY26)

    140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran

  • Khaitan Chemicals & Fertilizers Ltd (Q2 FY26)

    Q2-FY26 Operational Revenue: INR 3,086 million, up 33.8% year-on-year (Q2-FY25: INR 2,306 million). Key investor presentation takeaways from Khaitan Chemical's

  • Krishana Phosch. (Q2 FY26)

    Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions. Key concall takeaways from Krishana Phoschem…

  • Sumitomo Chemical India Ltd (Q2 FY26)

    Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Rama Phosphates and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Rama Phosphates Q2 FY26 results?

Revenue from Operations for Q2 FY26: ₹24,566 Lacs - Year-on-Year (Y-o-Y) increase in revenue: 17% (up by ₹3,620 Lacs from ₹20,946 Lacs in Q2 FY25) - Half Year (H1) Revenue FY26: ₹43,597 Lacs, up 20% from ₹36,315 Lacs in H1 FY25 - EBITDA for Q2 FY26: ₹2,711 lakh, up 149% year-on-year - PAT for Q2 FY26: ₹1,728 lakh, up 460% year-on-year - Year-on-year Revenue increase: 17% for the quarter - Margin Outlook: The presentation states strong fundamentals and robust growth, with an emphasis on leveraging technology and proactive R&D to create growth opportunities.

What is Rama Phosphates share price analysis?

Rama Phosphates currently shows a neutral. The stock trades at a P/E of 7.2 with a market cap of ₹385 Cr. Investors should review the full earnings analysis for detailed insights.

Is Rama Phosphates planning capital expenditure?

Dhule Project: - Phase 1: SSP Plant capacity 216,000 MT - CAPEX till Q2 FY26: ₹30.41 Cr (₹0.97 Cr funded through term loan) - Plant & machinery procured - Trial production expected by Q4

Keep Rama Phosphates on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.